Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma-Reference-Cited by-同舟云学术

Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma

Published:2005 Issue:2 Volume:103 Page:329-338
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Reardon David A.,Quinn Jennifer A.,Vredenburgh James,Rich Jeremy N.,Gururangan Sridharan,Badruddoja Michael,Herndon James E.,Dowell Jeannette M.,Friedman Allan H.,Friedman Henry S.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference55 articles.

1. Outcomes and Prognostic Factors in Recurrent Glioma Patients Enrolled Onto Phase II Clinical Trials

2. Specific Genetic Predictors of Chemotherapeutic Response and Survival in Patients With Anaplastic Oligodendrogliomas

3. Alterations of Chromosome Arms 1p and 19q as Predictors of Survival in Oligodendrogliomas, Astrocytomas, and Mixed Oligoastrocytomas

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. METTL3-mediated m6A modification of LINC00839 maintains glioma stem cells and radiation resistance by activating Wnt/β-catenin signaling;Cell Death & Disease;2023-07-12

2. Heterocycles in Breast Cancer Treatment: The Use of Pyrazole Derivatives;Current Medicinal Chemistry;2023-03

3. Repurposing drugs in glioblastoma;New Insights Into Glioblastoma;2023

4. A Potential New Treatment for High-Grade Glioma: A Study Assessing Repurposed Drug Combinations against Patient-Derived High-Grade Glioma Cells;Cancers;2022-05-25

5. N-2-(phenylamino) benzamide derivatives as novel anti-glioblastoma agents: Synthesis and biological evaluation;European Journal of Medicinal Chemistry;2021-12